Nephro-Urology Monthly

Published by: Kowsar

Adherence to Antihypertensives in Patients With Comorbid Condition

Zahra Saadat 1 , Farahnaz Nikdoust 2 , Hossein Aerab-Sheibani 3 , Mostafa Bahremand 4 , * , Elham Shobeiri 5 , Habibollah Saadat 1 , Yashar Moharramzad 1 and Donald E. Morisky 6
Authors Information
1 Department of Cardiology, Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Cardiology, Shahid Sadoughi University of Medical Sciences, Bafgh,Kermanshah, IR Iran
4 Department of Cardiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
5 Department of Radiology, Kermanshah University of Medical Sciences,Kermanshah, IR Iran
6 Department of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, USA
Article information
  • Nephro-Urology Monthly: July 01, 2015, 7 (4); e29863
  • Published Online: July 30, 2015
  • Article Type: Research Article
  • Received: May 10, 2015
  • Revised: July 28, 2015
  • Accepted: July 11, 2015
  • DOI: 10.5812/numonthly.29863

To Cite: Saadat Z, Nikdoust F, Aerab-Sheibani H, Bahremand M, Shobeiri E, et al. Adherence to Antihypertensives in Patients With Comorbid Condition, Nephro-Urol Mon. 2015 ; 7(4):e29863. doi: 10.5812/numonthly.29863.

Abstract
Copyright © 2015, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5): 487-97[DOI][PubMed]
  • 2. Delamater AM. Improving patient adherence. Clin Diabetes. 2006; 24(2): 71-7
  • 3. Carretero OA, Oparil S. Essential hypertension : part II: treatment. Circulation. 2000; 101(4): 446-53[PubMed]
  • 4. Krousel-Wood M, Islam T, Muntner P, Holt E, Joyce C, Morisky DE, et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med. 2010; 40(3): 248-57[DOI][PubMed]
  • 5. Ghembaza MA, Senoussaoui Y, Tani MK, Meguenni K. Impact of patient knowledge of hypertension complications on adherence to antihypertensive therapy. Curr Hypertens Rev. 2014; 10(1): 41-8[PubMed]
  • 6. An J, Nichol MB. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care. 2013; 51(10): 879-87[DOI][PubMed]
  • 7. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008; 28(4): 437-43[DOI][PubMed]
  • 8. Scalco AZ, Scalco MZ, Azul JBS, Lotufo Neto F. Hypertension and depression. Clinics. 2005; 60(3): 241-50
  • 9. Natarajan N, Putnam W, Van Aarsen K, Beverley Lawson K, Burge F. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician. 2013; 59(2)[PubMed]
  • 10. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006; 166(17): 1836-41[DOI][PubMed]
  • 11. Friedman O, McAlister FA, Yun L, Campbell NR, Tu K, Canadian Hypertension Education Program Outcomes Research T. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario. Am J Med. 2010; 123(2): 173-81[DOI][PubMed]
  • 12. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008; 23(5): 588-94[DOI][PubMed]
  • 13. Inkster ME, Donnan PT, MacDonald TM, Sullivan FM, Fahey T. Adherence to antihypertensive medication and association with patient and practice factors. J Hum Hypertens. 2006; 20(4): 295-7[DOI][PubMed]
  • 14. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2011; 64(3): 255
  • 15. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5): 348-54[PubMed]
  • 16. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009; 15(1): 59-66[PubMed]
  • 17. Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients. Glob J Health Sci. 2015; 7(4): 41252[DOI][PubMed]
  • 18. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6): 2089-100[DOI][PubMed]
  • 19. Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013; 12(1): 57[DOI][PubMed]
  • 20. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165(10): 1147-52[DOI][PubMed]
  • 21. Breitscheidel L, Ehlken B, Kostev K, Oberdiek MS, Sandberg A, Schmieder RE. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. J Med Econ. 2012; 15(1): 155-65[DOI][PubMed]
  • 22. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006; 296(21): 2563-71[DOI][PubMed]
  • 23. Mant J, McManus RJ. Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control. J Hum Hypertens. 2006; 20(8): 551-3[DOI][PubMed]
  • 24. Hacihasanoglu Asilar R, Gozum S, Capik C, Morisky DE. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg. 2014; 14(8): 692-700[DOI][PubMed]
  • 25. de Oliveira-Filho AD, Morisky DE, Neves SJ, Costa FA, de Lyra DJ. The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults. Res Social Adm Pharm. 2014; 10(3): 554-61[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments